Nyhet

AdjuTec Pharma joins forces to fight antibiotic resistance

Nyhet från Biostock

Publicerad: 26 Mar 13:59

AdjuTec Pharma has launched a research collaboration with India’s Venus Remedies Limited to combat the escalating threat of antimicrobial resistance.

With its lead candidate, APC-148, already in phase I trials, AdjuTec aims to breathe new life into – and restore the power of – existing antibiotics against multidrug-resistant bacteria.

Lorem ipsum dolor sit amet. Est omnis iusto eos velit nostrum et pariatur quod non. Consequuntur nemo id dolores tempora ut quis quis eum. Porro dolore rem voluptas iste. Consequuntur nemo id dolores tempora ut quis quis eum

•Denna källa har få eller inga artiklar bakom betalvägg

Läs hela artikeln hos Biostock

Börskollen

För dig med koll på börsen

Nyhet

AdjuTec Pharma joins forces to fight antibiotic resistance

Nyhetsbrev